CompletedPhase 1NCT00004056
Combination Chemotherapy Followed by Melphalan and Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Acute Myeloid Leukemia
Studying Acute erythroid leukemia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Oncology Group
- Principal Investigator
- Craig A. Hurwitz, MD, MDMaine Children's Cancer Program at Barbara Bush Children's Hospital
- Intervention
- filgrastim(biological)
- Enrollment
- 35 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 1999 – 2007
Study locations (20)
- University of Alabama Comprehensive Cancer Center, Birmingham, Alabama, United States
- Arizona Cancer Center, Tucson, Arizona, United States
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- Lucile Packard Children's Hospital at Stanford, Palo Alto, California, United States
- Children's Hospital and Health Center, San Diego, California, United States
- Nemours Children's Clinic, Jacksonville, Florida, United States
- Emory University Hospital - Atlanta, Atlanta, Georgia, United States
- Children's Memorial Hospital, Chicago, Chicago, Illinois, United States
- Maine Children's Cancer Program, Scarborough, Maine, United States
- Johns Hopkins Oncology Center, Baltimore, Maryland, United States
- Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
- Children's Hospital of Michigan, Detroit, Michigan, United States
- Cardinal Glennon Children's Hospital, St Louis, Missouri, United States
- Hackensack University Medical Center, Hackensack, New Jersey, United States
- Tomorrows Children's Institute, Hackensack, New Jersey, United States
- +5 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00004056 on ClinicalTrials.govOther trials for Acute erythroid leukemia
Additional recruiting or active studies for the same condition.